A limited number of medicines pragmatic trials had potential for waived informed consent following the 2016 CIOMS ethical guidelines
Rafael Dal‐Ré, C. Avendaño, Anthonius de Boer, Stephan K. James, Frits R. Rosendaal, Richard Stephens, John P. A. Ioannidis (2019). A limited number of medicines pragmatic trials had potential for waived informed consent following the 2016 CIOMS ethical guidelines. Journal of Clinical Epidemiology, 114, pp. 60-71, DOI: 10.1016/j.jclinepi.2019.06.007.
